iCAD Hosts Free Virtual Roundtable Event Focusing on Making Informed Decisions for Adopting New AI Solutions and Practical Applications in Healthcare

Leading experts in multiple disciplines to share best practices on leveraging AI in clinical settings

NASHUA, N.H., Sept. 09, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will host a free virtual roundtable event for clinicians, titled “What is Real AI: Adopting Artificial Intelligence,” on September 15, 2020 at 7 pm ET/4 pm PT. Event registration is available via this link: https://register.gotowebinar.com/register/1600095491848475917.

“This unique event provides a rare opportunity to learn from leading experts in multiple disciplines hailing from influential companies focused on the criteria for making AI decisions in clinical settings to enhance patient care,” according to Stacey Stevens, President of iCAD, Inc. “As we have seen with the commercial success of ProFound AI following its FDA-clearance in December 2018, demand continues to grow for clinically proven solutions that can streamline workflow and improve outcomes. In recent months the COVID-19 pandemic has severely impacted cancer screening – for many types of cancer, including breast – further underscoring the need for clinicians to be educated about the latest innovations that can increase accuracy and efficiency, which may help to manage the backlog of patients who need to be screened. We are pleased to host this educational event, and to provide a forum for clinicians to learn about the latest in AI technology so they may make more informed decisions with knowledge of the appropriate evaluation criteria when adopting AI technology into their practices.”

The roundtable will feature specialists in AI and cancer screening, including the following leading experts*:             

• Grant Davies, CEO, Solis Mammography (panelist)
• Randy Hicks, MD, MBA, Co-owner and CEO of Regional Medical Imaging (panelist)
• Senthil Periaswamy, PhD, Chief Research Scientist, VP of Clinical Innovation, iCAD, Inc. (panelist)
• Greg Sorensen, MD, CEO and Co-founder of DeepHealth, Inc. (panelist)
• Lawrence Tanenbaum, MD, CTO, Director of Advanced Imaging, VP, Radnet Inc. (panelist)
• Susan Wood, PhD, President and CEO, VIDA (moderator)

During the event, panelists will discuss the latest AI solutions for cancer screening and the benefits AI technology offers to clinicians and patients alike. The goal of this event is to educate clinicians about the value of AI in clinical practice, in the era of COVID-19 and moving forward.